BioPharma Dive November 7, 2025
Emily Olsen

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries with participating pharmaceutical manufacturers.

Dive Brief:

  • The CMS’ Innovation Center is launching a new payment model that aims to lower drug spending in Medicaid, the agency said Thursday.
  • Under the voluntary model, which will run for five years starting in January, the CMS will negotiate lower prices linked to those paid in select other countries with participating pharmaceutical companies.
  • The agency is now seeking applications from manufacturers interested in participating in the model, as well as letters of intent from states that may want to opt into the pricing and terms eventually negotiated...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicaid, Pharma, Pharma / Biotech
Reengineering ACOs To Make Medicare Competitive
Major CMS‑Recognized Hospital Types
No Surprises disputes increasing even as arbiters catch up, CMS says
CMS proposes nearly flat Medicare Advantage payments for 2027: 6 notes
The Persistent Rising Tide of U.S. Health Care Spending

Share Article